May 15, 2020

InSysBio announces its participation in AACR Virtual Annual Meeting II June 22-24, American Association for Cancer Research Annual Meeting which is held virtually this year due to COVID-19 spread. Today InSysBio team’s abstracts were published on AACR website, namely:

(Session PO.IM02.10 - Immune Checkpoints 2)

• “Prediction and comparison of PD-1 receptor occupancy in the tumor after treatment with immune checkpoint inhibitors” by Dmitry Shchelokov, Oleg Demin Jr;

(Session PO.BSB02.02 - Mathematical Modeling)

• “Prediction of target receptor occupancy for ALX148, a CD47 blocker, using mechanistic PK/RO modeling” by Elena Vasileva12, Oleg Demin Jr2
  Affiliation: 1 Lomonosov Moscow State University, Moscow, Russia; 2InSysBio, Moscow, Russia

Posters are going to be published on June 22, 2020, 9:00 AM

About InSysBio

InSysBio is a Quantitative Systems Pharmacology (QSP) company located in Moscow, Russia (INSYSBIO LLC) and Edinburgh, UK (INSYSBIO UK LIMITED). InSysBio was founded in 2004 and has an extensive track record of helping pharmaceutical companies to make right decisions on the critical stages of drug research and development by application of QSP modeling. InSysBio’s innovative QSP approach has already become a part of the drug development process implemented by our strategic partners: there are more than 100 completed projects in collaboration with leaders of pharmaceutical industry. For more information about InSysBio, its solutions and services, visit www.insysbio.com.

Share